{"id":4508,"date":"2018-06-22T21:15:18","date_gmt":"2018-06-23T01:15:18","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4508"},"modified":"2018-06-22T21:15:59","modified_gmt":"2018-06-23T01:15:59","slug":"ipo-weekly-recap-biotech-bingo","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-biotech-bingo\/","title":{"rendered":"IPO Weekly Recap: Biotech Bingo!"},"content":{"rendered":"<p><em><span style=\"font-weight: 400;\">Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the <\/span><b>TRUEST<\/b><span style=\"font-weight: 400;\"> picture of how an IPO is shaping up prior to its debut. We are on <\/span><b>your team. <\/b><span style=\"font-weight: 400;\">Additionally, we provide comprehensive research to outline short and long term risks of the new companies\u2026.. <\/span><b>A full-service firm!<\/b><\/em><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4509\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM.png\" alt=\"Screen Shot 2018-06-22 at 9.10.54 PM\" width=\"1241\" height=\"288\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM.png 1241w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM-600x139.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM-300x70.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.10.54-PM-1024x238.png 1024w\" sizes=\"(max-width: 1241px) 100vw, 1241px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><b>Biotech bingo <\/b><span style=\"font-weight: 400;\">hit across the board as the seven in the sector averaged 26.7% returns at first trade. <\/span><\/p>\n<p><img decoding=\"async\" class=\"aligncenter size-full wp-image-4401\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AUTL.jpg\" alt=\"AUTL\" width=\"219\" height=\"51\" \/><img decoding=\"async\" class=\"aligncenter size-full wp-image-4421\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AVRO.jpg\" alt=\"AVRO\" width=\"181\" height=\"46\" \/><\/p>\n<p><span style=\"font-weight: 400;\">The two best of the week turned out to be <\/span><b>Autolus Therapeutics (AUTL) <\/b><span style=\"font-weight: 400;\">and <\/span><b>AVROBio, Inc (AVRO) <\/b><span style=\"font-weight: 400;\">which opened 65% and 54% above their offering prices, respectfully. <\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4429\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EIDX.jpg\" alt=\"EIDX\" width=\"196\" height=\"72\" \/><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4417\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/KZR.jpg\" alt=\"KZR\" width=\"221\" height=\"43\" \/><\/p>\n<p><b>Kezar Life Sciences (KZR) <\/b><span style=\"font-weight: 400;\">and <\/span><b>Eidos Therapeutics (EIDX) <\/b><span style=\"font-weight: 400;\">fell in line nicely with opening trades of +33% and +18% versus their offering prices, respectfully. EIDX, which batted lead-off on biotech week, traded as high as $24.75 on its opening day for a return of 46% above its $17.00 offering price. <\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4405\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/XERS.jpg\" alt=\"XERS\" width=\"230\" height=\"80\" \/><\/p>\n<p><b>Xeris Pharmaceuticals (XERS)<\/b><span style=\"font-weight: 400;\"> opened with a $0.75 premium above its $15.00 issue price and also traded very well &#8212; touching $20.28 during its debut day. <\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4425\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/APTX.jpg\" alt=\"APTX\" width=\"223\" height=\"62\" \/><b>Aptinyx Inc (APTX) <\/b><span style=\"font-weight: 400;\">enjoyed a 8.7% return at first trade with a $17.40 opening following its issuance of shares at $16.00. APTX traded as high as $20.88 in its opening week. <\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4409\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA.jpg\" alt=\"Magenta_logo\" width=\"405\" height=\"113\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA.jpg 405w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA-300x84.jpg 300w\" sizes=\"(max-width: 405px) 100vw, 405px\" \/><\/p>\n<p><b>Magenta Therapeutics (MGTA)<\/b><span style=\"font-weight: 400;\"> opened $0.50 above its $15.00 issue price and traded to as high as $16.33 early on but succumbed to selling pressure and was the only biotech to trade below its issue price in the opening week.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4397\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/ECOR.jpg\" alt=\"ECOR\" width=\"191\" height=\"54\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Medical device company, <\/span><b>Electrocore LLC (ECOR)<\/b><span style=\"font-weight: 400;\">, upsized its offering and priced at the midpoint of the range, $15.00. ECOR opened 20% above the offering price with a first trade of $18.00.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4413\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/IIIV.jpg\" alt=\"IIIV\" width=\"268\" height=\"188\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Outside of the healthcare sector, <\/span><b>i3 Verticals (IIIV)<\/b><span style=\"font-weight: 400;\">, debuted with strength as expected. After pricing at the high end of the range, $13.00, IIIV opened at $18.00 for a gain of 38.5% at first trade. <\/span><b>Essential Properties Trust (EPRT) <\/b><span style=\"font-weight: 400;\">priced at the low-end of its range, $14.00 and opened $0.51 below issue. EPRT did not trade above its IPO price during its opening week- at the time of this writing.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4433\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EPRT.jpg\" alt=\"Microsoft Word - Essential Properties - Draft S-11 1-22-18.docx\" width=\"268\" height=\"53\" \/><\/p>\n<p><span style=\"font-weight: 400;\">As for this week, it will be the \u2018final rush\u2019 ahead of the July 4th holiday week as twelve IPOs are coming to market. Click on the logo to read a preview of each IPO!\\<a href=\"http:\/\/www.ipoboutique.com\/blog\/unix-limited-ipo-preview-uxin\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4499\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-11.11.38-AM.png\" alt=\"Screen Shot 2018-06-22 at 11.11.38 AM\" width=\"106\" height=\"79\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/tricida-inc-ipo-preview-tcda\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4496\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/TCDA.jpg\" alt=\"PowerPoint Presentation\" width=\"196\" height=\"49\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/translate-bio-inc-ipo-preview-tbio\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4492\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/TBIO.jpg\" alt=\"TBIO\" width=\"108\" height=\"106\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/the-lovesac-company-ipo-preview-love\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4486\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/LOVE.jpg\" alt=\"LOVE\" width=\"476\" height=\"122\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/LOVE.jpg 476w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/LOVE-300x77.jpg 300w\" sizes=\"(max-width: 476px) 100vw, 476px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/neuronetics-inc-ipo-preview-stim\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4481\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/STIM.png\" alt=\"STIM\" width=\"368\" height=\"54\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/STIM.png 368w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/STIM-300x44.png 300w\" sizes=\"(max-width: 368px) 100vw, 368px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/neon-therapeutics-inc-ipo-preview-ntgn\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4477\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/NTGN.jpg\" alt=\"NTGN\" width=\"301\" height=\"116\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/NTGN.jpg 301w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/NTGN-300x116.jpg 300w\" sizes=\"(max-width: 301px) 100vw, 301px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/goodbulk-ltd-ipo-preview-gblk\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4473\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/GBLK.png\" alt=\"GBLK\" width=\"327\" height=\"84\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/GBLK.png 327w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/GBLK-300x77.png 300w\" sizes=\"(max-width: 327px) 100vw, 327px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/forty-seven-inc-ftsv-ipo-preview\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4467\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/FTSV.jpg\" alt=\"FTSV\" width=\"336\" height=\"65\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/FTSV.jpg 336w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/FTSV-300x58.jpg 300w\" sizes=\"(max-width: 336px) 100vw, 336px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/everquote-inc-ipo-preview-ever\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4463\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EVER.jpg\" alt=\"EVER\" width=\"304\" height=\"40\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EVER.jpg 304w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EVER-300x39.jpg 300w\" sizes=\"(max-width: 304px) 100vw, 304px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/domo-inc-ipo-preview-domo\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4459\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/DOMO.png\" alt=\"DOMO\" width=\"135\" height=\"124\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/brightview-holdings-ipo-preview-bv\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4455\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/BV.jpg\" alt=\"BV\" width=\"288\" height=\"101\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/bjs-wholesale-club-holdings-inc-ipo-preview-bj\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4451\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/BJ.jpg\" alt=\"BJ\" width=\"125\" height=\"99\" \/><\/a><\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4508","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4508"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4508\/revisions"}],"predecessor-version":[{"id":4510,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4508\/revisions\/4510"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}